Overview

Cardiovascular Information System Market Introduction

Cardiovascular information system market is estimated to value over US$ 1 billion by the end of 2027 and record at a CAGR of over 7.8% during the forecast period of 2020-2027.

Cardiovascular system comprises the blood vessels and heart and It carries nutrients and oxygen to other parts of the body and removes carbon dioxide from them. Cardiovascular information system enlightened database system maintained by a cardiologist (specially trained medical professionals in heart-related treatments) used to manage the data of patient treatment programs, the enormous images files like 2D echo, ECG and MRI etc, treatment summaries and results created during the course of treatment and diagnosis. This CVIS is a special kind of Electronic health record used in cardiology to streamline patient care, improves employee work accuracy, better communications with referred doctors and image/ cardiology asset accessibility.

Rising demand for information systems in healthcare services is expected to fuel the growth of cardiovascular information systems market. They are advantageous over traditional methods of data handling and validations and decreased the manual effort and improved the efficiency of the process. Along with this, the cardiovascular information system has a tremendous demand in healthcare settings due to the high patient pool and boosted the growth of the market. Further, increasing capital investment by healthcare sectors has created potential opportunities for robust growth of cardiovascular information systems market. Additionally, cardiovascular information system improves the patient care and helps in better management of cardiac disorders. 

Cardiovascular information system market is dominated by North America and Europe due to the high adoption rate among the end users and expected to remain dominant throughout the forecast period. Changing economic conditions and increasing awareness of population in the Asia Pacific region is expected to create a number of opportunities for cardiovascular information system service provides. Latin America and Rest of World Cardiovascular information systems market are expected to account a small share in the global market.

Cardiovascular Information Systems market players include:

Siemens Healthcare, Elekta AB, GE Healthcare, AGFA Healthcare, Koninklijke Philips N.V., Fujifilm Medical Systems and others

Cardiovascular Information System Market Segmentation:

By Deployment

• On-Premise
• Remote
• Cloud-Based

By End User

• Hospitals
• Diagnostic Laboratories
• Outpatient Centres
• Clinics

By Region

• Europe  
• North America  
• APAC  
• Latin America
• Rest of World

Competitive Landscape:  

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants  

FutureWise Takeaways  

• Growth prospects  
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth  

Objectives of the Study:

• To provide with an exhaustive analysis on global cardiovascular information system market by deployment type, end-user and region 
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market  
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

Table of Contents

1. Market Introduction
          1.1 Objectives of the Study 
          1.2 Market Definition 
          1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
          1.4 Currency 
          1.5 Limitations 
          1.6 Stakeholders 
 2.  Research Methodology 
      2.1 Research Data 
         2.1.1 Secondary Data
                 2.1.1.1 Key Data From Secondary Sources
         2.1.2 Primary Data
                 2.1.2.1 Key Data From Primary Sources
      2.2 Market Size Estimation 
      2.3 Market Breakdown and Data Triangulation 
      2.4 Assumptions for the Study  
3. Executive Summary
        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights
4. Global Clinical Trials Imaging Techniques Market Variables, Trends & Scope
       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards And Compliances
5. Global Clinical Trials Imaging Techniques Market Overview
     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Clinical Trials Imaging Techniques Market Analysis Tools
         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies
7. Global Clinical Trials Imaging Techniques Market, By DeploymentHistorical Analysis and Forecast 2020-2027 (USD Million)
          7.1. On-Premise
          7.2. Remote
          7.3. Cloud-Based
8. Global Clinical Trials Imaging Techniques Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
           8.1. Hospitals
           8.2. Diagnostic Laboratories
          8.3. Outpatient Centres
          8.4. Clinics
9.  North America Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     9.1. Introduction
     9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            9.2.1. U.S.A
            9.2.2. Canada
     9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Europe Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
     10.1. Introduction
     10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            10.2.1. Germany
            10.2.2. U.K
           10.2.3. France
           10.2.4. Italy
           10.2.5. Spain
           10.2.6. Russia
           10.2.7. Poland
           10.2.8. Switzerland
           10.2.9.Rest of Western Europe
11. Asia Pacific Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        11.1. Introduction
        11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             11.2.1. Japan
             11.2.2. China
             11.2.3. Singapore
             11.2.4. India
             11.2.5. Australia and New Zealand
             11.2.6. ASEAN
             11.2.7. South Korea
             11.2.8. Rest of Asia Pacific
        11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
12. Middle East and Africa Skin Perfusion Pressure Testing Device Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        12.1. Introduction
        12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             12.2.1. Saudi Arabia
             12.2.2. UAE
             12.2.3. South Africa
             12.2.4. Egypt
        12.3. Market Size (USD Million) Forecast for MEA 2020-2027           
    13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
         13.1. Siemens Healthcare
                13.1.1. Company Overview
                13.1.2. Product Portfolio
                13.1.3. SWOT Analysis
                13.1.4. Financial Overview
                13.1.5. Strategic Overview
         13.2. Elekta AB
                13.2.1. Company Overview
                13.2.2. Product Portfolio
                13.2.3. SWOT Analysis
                13.2.4. Financial Overview
                13.2.5. Strategic Overview
         13.3. GE Healthcare
                13.3.1. Company Overview
                13.3.2. Product Portfolio
                13.3.3. SWOT Analysis
                13.3.4. Financial Overview
                13.3.5. Strategic Overview
         13.4. AGFA Healthcare
                13.4.1. Company Overview
                13.4.2. Product Portfolio
                13.4.3. SWOT Analysis
                13.4.4. Financial Overview
                13.4.5. Strategic Overview
         13.5. Koninklijke Philips N.V.
                13.5.1. Company Overview
                13.5.2. Product Portfolio
                13.5.3. SWOT Analysis
                13.5.4. Financial Overview
                13.5.5. Strategic Overview
         13.6. Fujifilm Medical Systems
                13.6.1. Company Overview
                13.6.2. Product Portfolio
                13.6.3.  SWOT Analysis
                13.6.4. Financial Overview
                13.6.5. Strategic Overview
14. FutureWise SME key takeaway points for Client

Tables

Figures